Additional file 1: Table S1. of A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

C. H. Wang (Creator)
Li Tzong Chen (Contributor)
Nai Jung Chiang (Contributor)
C. Grace Yeh (Contributor)
Ruey Kuen Hsieh (Contributor)
Tsu-Yi Chao (Contributor)
Yi Wen Wang (Creator)

Dataset

Description

Tumor type, dose level, DLT, best response and single nucleotide polymorphisms of UGT1A1*28 and UGT1A1*6. (DOCX 18Â kb)

Date made available	2016
Publisher	Figshare

DOI
10.6084/m9.figshare.c.3646481_d1.v1

Access Dataset

CC BY + CC0

1 Article

A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors
Chiang, N. J., Chao, T. Y., Hsieh, R. K., Wang, C. H., Wang, Y. W., Yeh, C. G. & Chen, L. T., Nov 21 2016, In: BMC Cancer. 16, 1, 907.
Research output: Contribution to journal › Article › peer-review

Open Access
36 Citations (Scopus)

Cite this

Wang, C. (Creator), Chen, L. (Contributor), Chiang, N. (Contributor), Yeh, C. G. (Contributor), Hsieh, R. (Contributor), Chao, T. (Contributor), Wang, Y. (Creator) (2016). Additional file 1: Table S1. of A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors. Figshare. 10.6084/m9.figshare.c.3646481_d1.v1

Additional file 1: Table S1. of A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

Description

DOI

Access Dataset

Research output

A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

Cite this